Literature DB >> 7479695

Structural basis for serpin inhibitor activity.

H T Wright1, J N Scarsdale.   

Abstract

The mechanism of formation and the structures of serpin-inhibitor complexes are not completely understood, despite detailed knowledge of the structures of a number of cleaved and uncleaved inhibitor, noninhibitor, and latent serpins. It has been proposed from comparison of inhibitor and noninhibitor serpins in the cleaved and uncleaved forms that insertion of strand s4A into preexisting beta-sheet A is a requirement for serpin inhibitor activity. We have investigated the role of this strand in formation of serpin-proteinase complexes and in serpin inhibitor activity through homology modeling of wild type inhibitor, mutant substrate, and latent serpins, and of putative serpin-proteinase complexes. These models explain the high stability of the complexes and provide an understanding of substrate behavior in serpins with point mutations in s4A and of latency in plasminogen activator inhibitor I.

Mesh:

Substances:

Year:  1995        PMID: 7479695     DOI: 10.1002/prot.340220303

Source DB:  PubMed          Journal:  Proteins        ISSN: 0887-3585


  20 in total

1.  Role of Lys335 in the metastability and function of inhibitory serpins.

Authors:  H Im; M H Yu
Journal:  Protein Sci       Date:  2000-05       Impact factor: 6.725

2.  Formation of the covalent serpin-proteinase complex involves translocation of the proteinase by more than 70 A and full insertion of the reactive center loop into beta-sheet A.

Authors:  E Stratikos; P G Gettins
Journal:  Proc Natl Acad Sci U S A       Date:  1999-04-27       Impact factor: 11.205

3.  Regulation of protein function by native metastability.

Authors:  C Lee; S H Park; M Y Lee; M H Yu
Journal:  Proc Natl Acad Sci U S A       Date:  2000-07-05       Impact factor: 11.205

4.  Probing the serpin structural-transition mechanism in ovalbumin mutant R339T by proteolytic-cleavage kinetics of the reactive-centre loop.

Authors:  Yasuhiro Arii; Masaaki Hirose
Journal:  Biochem J       Date:  2002-04-15       Impact factor: 3.857

5.  Cavities of alpha(1)-antitrypsin that play structural and functional roles.

Authors:  C Lee; J S Maeng; J P Kocher; B Lee; M H Yu
Journal:  Protein Sci       Date:  2001-07       Impact factor: 6.725

6.  Crystal structure of viral serpin crmA provides insights into its mechanism of cysteine proteinase inhibition.

Authors:  M Simonovic; K Volz
Journal:  Protein Sci       Date:  2000-08       Impact factor: 6.725

Review 7.  Limitations of conventional anticoagulant therapy and the promises of non-heparin based conformational activators of antithrombin.

Authors:  Qudsia Rashid; Poonam Singh; Mohammad Abid; Mohamad Aman Jairajpuri
Journal:  J Thromb Thrombolysis       Date:  2012-08       Impact factor: 2.300

8.  Serpin alpha 1proteinase inhibitor probed by intrinsic tryptophan fluorescence spectroscopy.

Authors:  H Koloczek; A Banbula; G S Salvesen; J Potempa
Journal:  Protein Sci       Date:  1996-11       Impact factor: 6.725

9.  Major proteinase movement upon stable serpin-proteinase complex formation.

Authors:  E Stratikos; P G Gettins
Journal:  Proc Natl Acad Sci U S A       Date:  1997-01-21       Impact factor: 11.205

10.  The length of the reactive center loop modulates the latency transition of plasminogen activator inhibitor-1.

Authors:  Yu-Ran Na; Hana Im
Journal:  Protein Sci       Date:  2004-12-02       Impact factor: 6.725

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.